Trial NCT03769467

View at ClinicalTrials.gov 
Org. Study IDs: ATA129-NPC-202
Secondary IDs: KEYNOTE PN597

Last trial update was posted on 2022-09-30

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Epstein-Barr Virus Infections Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms Neoplasms Viremia Virus Diseases

Other Conditions

Epstein-Barr Viraemia Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Stopping Reasons

Phase 1B part was completed with review of DLTs and cumulative safety data by Safety Data Review Committee and identification of a safe RP2D. Post-internal review, sponsor decided to terminate the study, and hence, Phase 2 part was not conducted.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID